KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Non-Current Debt (2016 - 2025)

Amgen (AMGN) has 17 years of Non-Current Debt data on record, last reported at $50.0 billion in Q4 2025.

  • For Q4 2025, Non-Current Debt fell 11.57% year-over-year to $50.0 billion; the TTM value through Dec 2025 reached $50.0 billion, down 11.57%, while the annual FY2025 figure was $50.0 billion, 11.57% down from the prior year.
  • Non-Current Debt reached $50.0 billion in Q4 2025 per AMGN's latest filing, down from $52.4 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $63.2 billion in Q4 2023 and bottomed at $28.5 billion in Q2 2021.
  • Average Non-Current Debt over 5 years is $47.8 billion, with a median of $53.1 billion recorded in 2025.
  • Peak YoY movement for Non-Current Debt: fell 16.63% in 2021, then skyrocketed 69.11% in 2023.
  • A 5-year view of Non-Current Debt shows it stood at $33.2 billion in 2021, then grew by 12.44% to $37.4 billion in 2022, then surged by 69.11% to $63.2 billion in 2023, then fell by 10.48% to $56.5 billion in 2024, then decreased by 11.57% to $50.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $50.0 billion in Q4 2025, $52.4 billion in Q3 2025, and $53.8 billion in Q2 2025.